The PASCAL system, a novel edge-to-edge repair device, was shown to be noninferior to the well-established MitraClip device in terms of major adverse events. The approval by the U.S. Food and Drug ...
The MitraClip is a single-size clip device that has been used to treat patients with functional, mixed and degenerative MR. The Clip has a dual arm structure, with grippers above the arms to ...
Mitraclip is a groundbreaking procedure transforming cardiac care by treating mitral valve regurgitation. This minimally invasive treatment offers new hope for patients with heart conditions. Listen ...
In a series of tweets, Das extended his thanks to Finance Minister Nirmala Sitharaman, various stakeholders, including financial sector participants, economists, industry bodies. Listen to Story ...
In the trial, which included patients with significant, symptomatic MR (3+ or 4+) randomized to TEER with Pascal or MitraClip (Abbott), there was no significant difference in MR reduction, quality of ...
Surgical repair decreased MR more than MitraClip ®. In 12-month follow-up, 20% of MitraClip patients required surgery for mitral dysfunction versus 2% in surgical patients. Both groups had ...
Oz patented the Mitraclip, a small implantable clip that can be placed using a catheter to repair the heart’s mitral valve. Oz reported earning over $333,000 in royalties in his 2022 disclosures.